Jun-Mei Yi
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Cancer, Lipids, and Metabolism 3
-
- RNA modifications and cancer 3
- Cancer therapeutics and mechanisms 3
- Co-authors
- Xuejun Jiang (4 shared papers)Jiajun Zhu (3 shared papers)Craig B. Thompson (3 shared papers)Alexander M. Minikes (2 shared papers)Minghui Gao (1 shared paper)Prashant Monian (1 shared paper)Jiao Wu (1 shared paper)Raghu L. Vemuganti (1 shared paper)
- Journals
- Information Sciences (2 papers)Molecular Cancer Therapeutics (2 papers)Small (1 paper)Pharmacological Research (1 paper)Science (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Jun-Mei Yi
18 papers receiving 3.2k citations
Jun-Mei Yi's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 1.2k
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 1.7k
- Oncology 253
- Biochemistry 72
Countries citing papers authored by Jun-Mei Yi
This map shows the geographic impact of Jun-Mei Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Mei Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Mei Yi more than expected).
Fields of papers citing papers by Jun-Mei Yi
This network shows the impact of papers produced by Jun-Mei Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Mei Yi. The network helps show where Jun-Mei Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun-Mei Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Role of Mitochondria in Ferroptosis Hit paper breakdown → | 2018 | 1737 |
| 2 | Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis Hit paper breakdown → | 2020 | 774 |
| 3 | 2007 | 183 | |
| 4 | 2021 | 139 | |
| 5 | 2006 | 69 | |
| 6 | 2004 | 64 | |
| 7 | 2015 | 49 | |
| 8 | 2016 | 37 | |
| 9 | 2014 | 34 | |
| 10 | 2019 | 31 | |
| 11 | 2004 | 31 | |
| 12 | 2005 | 19 | |
| 13 | 2004 | 15 | |
| 14 | 2024 | 12 | |
| 15 | 2025 | 11 | |
| 16 | 2002 | 9 | |
| 17 | 2025 | 8 | |
| 18 | 1999 | 3 | |
| 19 | 2025 | 0 |
About Jun-Mei Yi
Jun-Mei Yi is a scholar working on Cancer Research, Molecular Biology, Control and Systems Engineering, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 19 papers that have together received 3.2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), RNA modifications and cancer (3 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer therapeutics and mechanisms (3 papers), Stability and Control of Uncertain Systems (2 papers), Nanoplatforms for cancer theranostics (1 paper), Handwritten Text Recognition Techniques (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Cancer Research (1.2k citations), Pulmonary and Respiratory Medicine (1.7k citations), Molecular Biology (1.7k citations), Oncology (253 citations) and Biochemistry (72 citations). Jun-Mei Yi has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xuejun Jiang, Jiajun Zhu, Craig B. Thompson, Alexander M. Minikes, Minghui Gao, Prashant Monian, Jiao Wu, Raghu L. Vemuganti, Soo‐Jin Park and Magdi S. Mahmoud. Their work appears in journals such as Information Sciences, Molecular Cancer Therapeutics, Small, Pharmacological Research and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.